BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 17081581)

  • 1. Characterization of the Epstein-Barr virus glycoprotein BMRF-2.
    Xiao J; Palefsky JM; Herrera R; Tugizov SM
    Virology; 2007 Mar; 359(2):382-96. PubMed ID: 17081581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Epstein-Barr virus BMRF-2 protein facilitates virus attachment to oral epithelial cells.
    Xiao J; Palefsky JM; Herrera R; Berline J; Tugizov SM
    Virology; 2008 Jan; 370(2):430-42. PubMed ID: 17945327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EBV BMRF-2 facilitates cell-to-cell spread of virus within polarized oral epithelial cells.
    Xiao J; Palefsky JM; Herrera R; Berline J; Tugizov SM
    Virology; 2009 Jun; 388(2):335-43. PubMed ID: 19394065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr virus infection of polarized tongue and nasopharyngeal epithelial cells.
    Tugizov SM; Berline JW; Palefsky JM
    Nat Med; 2003 Mar; 9(3):307-14. PubMed ID: 12592401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell growth and matrix invasion of EBV-immortalized human B lymphocytes is regulated by expression of alpha(v) integrins.
    Huang S; Stupack D; Liu A; Cheresh D; Nemerow GR
    Oncogene; 2000 Apr; 19(15):1915-23. PubMed ID: 10773881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracellular localization of the Epstein-Barr virus BFRF1 gene product in lymphoid cell lines and oral hairy leukoplakia lesions.
    Farina A; Cardinali G; Santarelli R; Gonnella R; Webster-Cyriaque J; Bei R; Muraro R; Frati L; Angeloni A; Torrisi MR; Faggioni A
    J Med Virol; 2004 Jan; 72(1):102-11. PubMed ID: 14635017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of Epstein-Barr virus BMRF-2 and BDLF-3 genes in hairy leukoplakia.
    Peñaranda ME; Lagenaur LA; Pierik LT; Berline JW; MacPhail LA; Greenspan D; Greenspan JS; Palefsky JM
    J Gen Virol; 1997 Dec; 78 ( Pt 12)():3361-70. PubMed ID: 9400989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EBV-positive human sera contain antibodies against the EBV BMRF-2 protein.
    Xiao J; Palefsky JM; Herrera R; Sunshine C; Tugizov SM
    Virology; 2009 Oct; 393(1):151-9. PubMed ID: 19698968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistent productive Epstein-Barr virus replication in normal epithelial cells in vivo.
    Walling DM; Flaitz CM; Nichols CM; Hudnall SD; Adler-Storthz K
    J Infect Dis; 2001 Dec; 184(12):1499-507. PubMed ID: 11740724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epstein-Barr virus BMRF-2 and BDLF-3 expression in hairy leukoplakia.
    Palefsky JM; Peñaranda ME; Pierik LT; Lagenaur LA; MacPhail LA; Greenspan D; Greenspan JS
    Oral Dis; 1997 May; 3 Suppl 1():S171-6. PubMed ID: 9456683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.
    Niller HH; Wolf H; Minarovits J
    Autoimmunity; 2008 May; 41(4):298-328. PubMed ID: 18432410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A molecular link between malaria and Epstein-Barr virus reactivation.
    Chêne A; Donati D; Guerreiro-Cacais AO; Levitsky V; Chen Q; Falk KI; Orem J; Kironde F; Wahlgren M; Bejarano MT
    PLoS Pathog; 2007 Jun; 3(6):e80. PubMed ID: 17559303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune activation suppresses initiation of lytic Epstein-Barr virus infection.
    Ladell K; Dorner M; Zauner L; Berger C; Zucol F; Bernasconi M; Niggli FK; Speck RF; Nadal D
    Cell Microbiol; 2007 Aug; 9(8):2055-69. PubMed ID: 17419714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistence and transition of Epstein-Barr virus genotypes in the pathogenesis of oral hairy leukoplakia.
    Walling DM; Etienne W; Ray AJ; Flaitz CM; Nichols CM
    J Infect Dis; 2004 Jul; 190(2):387-95. PubMed ID: 15216477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of integrins, tetraspanins, and ADAM proteins during the development of apoptotic bodies by spermatogenic cells.
    Kierszenbaum AL; Rosselot C; Rivkin E; Tres LL
    Mol Reprod Dev; 2006 Jul; 73(7):906-17. PubMed ID: 16557522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identifying gp85-regions involved in Epstein-Barr virus binding to B-lymphocytes.
    Urquiza M; Suarez J; Lopez R; Vega E; Patino H; Garcia J; Patarroyo MA; Guzman F; Patarroyo ME
    Biochem Biophys Res Commun; 2004 Jun; 319(1):221-9. PubMed ID: 15158465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular uptake of the EBV transcription factor EB1/Zta.
    Mahot S; Fender P; Vivès RR; Caron C; Perrissin M; Gruffat H; Sergeant A; Drouet E
    Virus Res; 2005 Jun; 110(1-2):187-93. PubMed ID: 15845271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus in oral diseases.
    Slots J; Saygun I; Sabeti M; Kubar A
    J Periodontal Res; 2006 Aug; 41(4):235-44. PubMed ID: 16827715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Epstein-Barr virus replication on Langerhans cells in pathogenesis of oral hairy leukoplakia.
    Walling DM; Flaitz CM; Hosein FG; Montes-Walters M; Nichols CM
    J Infect Dis; 2004 May; 189(9):1656-63. PubMed ID: 15116302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr Virus (EBV): infection, propagation, quantitation, and storage.
    Lan K; Verma SC; Murakami M; Bajaj B; Robertson ES
    Curr Protoc Microbiol; 2007 Aug; Chapter 14():Unit 14E.2. PubMed ID: 18770612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.